RCAG
PGNX

Rehmann Capital Advisory Group’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Rehmann Capital Advisory Group’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-77
Closed -$619 – 2216
2018
Q2 		$619 Buy
77
+62
+413% +$498 ﹤0.01% 2041
2018
Q1 		$0 Buy
+15
New – ﹤0.01% 2074